Jagsonpal Pharmaceuticals appoints Manish Gupta as the MD
Manish led SeQuent since 2014 and played a major role in transforming the company
Manish led SeQuent since 2014 and played a major role in transforming the company
Operating EBITDA grew by 82.7 % to Rs. 14.4 crore, EBITDA margin at 23.9%, and Profit After Tax (PAT) grew by 47.1% to Rs. 7.8 crore
Narayanan to lead SeQuent through next phase of consolidation and growth
Formulation business grew by 15 per cent in the quarter
Subscribe To Our Newsletter & Stay Updated